How to Manage a Medical Equipment Procurement Pipeline

A procurement pipeline is the view of everything approved but not yet delivered, with expected dates at each stage. Organisations that maintain one can see where a year is becoming congested and act. Organisations that do not tend to discover in the final quarter that most of the year's approvals are arriving at once, straining installation capacity and pushing commissioning into the next period.

This guide sets out how a pipeline is built and used. It covers the stages worth tracking, how realistic dates are set rather than assumed, what early slippage looks like, how the pipeline connects to capital budget phasing, why unspent capital is a governance problem rather than an accounting one, and how the record supports the next planning cycle. It is written for procurement, finance and clinical engineering teams across the UK, Europe, the US, the Gulf and South Africa.

What drives the decision — the short version

• Stages — Acceptance decision. Specification, tender, award, delivery, installation and commissioning, each with a date.

• Slippage — Visible early. A stage running late is a signal, not a surprise to be discovered at year-end.

• Phasing — Spread deliberately. Approvals arriving together overwhelm installation and delay commissioning.

Why approval is not delivery

Between a decision and a working device sits specification, market testing, tender, evaluation, award, any standstill period, contracting, manufacture, delivery, enabling works, installation, acceptance testing and training. Each has a duration, and several depend on parties the organisation does not control.

Treating approval as completion is what produces the annual pattern of everything landing at once. Services assume their equipment is coming, estates discover three installations scheduled in the same fortnight, and commissioning slips past year-end. None of that is visible without a pipeline, because each item looks fine considered alone.

Some stages carry obligations that cannot be compressed. Regulatory checks, including confirming registration status and any notices from bodies such as the MHRA, belong before contracting, not after. WHO guidance on health technology management treats installation and commissioning as part of the acquisition, and clinical guidance from NICE may set expectations that affect specification timing.

What a pipeline tracks

1. Approval date. When the decision was made and which budget period it falls under.

2. Specification status. Whether requirements are drafted, reviewed and ready to go to market.

3. Procurement route. Which process applies, and the minimum time that route requires.

4. Award and contracting. When award is expected, including any standstill and contract signature.

5. Manufacturing lead time. Supplier production and delivery schedules, confirmed rather than assumed.

6. Enabling works. Estates and IT preparation, which frequently gates installation more than delivery does.

7. Installation and commissioning. Scheduled dates, acceptance testing and the point the device becomes usable.

8. Training completion. When staff are competent to use it, since delivery without training is not capability.

How the criteria are applied

How the cycle typically runs

1. Every approved item enters the pipeline with expected dates for each stage.
2. Dates are set based on experience from similar procurements, not optimistic assumptions.
3. The pipeline is reviewed regularly, with slippage flagged rather than absorbed silently.
4. Congestion is identified early enough to rephase installations across the period.
5. Enabling works are scheduled alongside procurement rather than discovered at delivery.
6. Completion is recorded, so future timings can be estimated from what actually happened.

Delivered and usable: not the same milestone

Pipelines frequently treat delivery as the end point, which produces a misleading picture. A device delivered but not installed is not capability. A device installed but not commissioned cannot be used. A device commissioned but with no trained staff sits idle, sometimes for months, while the budget shows it as complete.

Tracking to the point of clinical use, rather than delivery, changes what the pipeline tells you. It also surfaces the stages that most often cause delay, which are rarely manufacturing. Enabling works and training are the usual culprits, and both are within the organisation's control if they are scheduled alongside procurement rather than triggered by a delivery notification.

What a working pipeline contains

• Every approved item, without exception. Including small purchases, since aggregate volume is what causes congestion.

• Realistic stage durations. Based on what similar procurements actually took, not on best-case assumptions.

• Enabling works scheduled in parallel. Estates and IT preparation running alongside procurement rather than after delivery.

• Tracking to clinical use. The milestone being usable capability, not the arrival of a crate.

• Regular review with flagged slippage. Delay surfaced while rephasing is still possible.

• Recorded actual durations. So the next cycle's estimates improve rather than repeating the same optimism.

Unspent capital and what it signals

Capital approved but not spent within the period is usually treated as a finance problem. It is more useful to read as a pipeline problem. Underspend generally means procurements started too late, enabling works were not scheduled, or lead times were underestimated, and all three are visible months in advance to anyone maintaining a pipeline.

It also carries a cost beyond the accounting. Services wait longer than the approval implied, and confidence in the planning process falls, which shows up as inflated requests next cycle. ISO-published quality management standards support consistent underlying records, and consistent records improve duration estimates rather than repeating them.

More from Business

• Buyers — source compliant, well-documented equipment.

• Suppliers — list your equipment and reach buyers worldwide.

Disclaimer

This page is for general information only and does not constitute procurement, financial, clinical, legal or regulatory advice. Procurement routes, stage durations, approval structures and capital accounting treatment vary by organisation, health system and country, and change over time. Nothing here should be treated as guidance on financial planning for any specific organisation. Always follow your own governance and financial procedures, and consult qualified procurement, finance, clinical and regulatory professionals for decisions specific to your organisation. medigear.uk accepts no liability for actions taken based on this content.